CN101899035A - 一种高纯度伊马替尼的制备方法 - Google Patents
一种高纯度伊马替尼的制备方法 Download PDFInfo
- Publication number
- CN101899035A CN101899035A CN 201010274002 CN201010274002A CN101899035A CN 101899035 A CN101899035 A CN 101899035A CN 201010274002 CN201010274002 CN 201010274002 CN 201010274002 A CN201010274002 A CN 201010274002A CN 101899035 A CN101899035 A CN 101899035A
- Authority
- CN
- China
- Prior art keywords
- pyridine
- methyl
- preparation
- solvent
- imatinib
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000005517 L01XE01 - Imatinib Substances 0.000 title claims abstract description 28
- 229960002411 imatinib Drugs 0.000 title claims abstract description 28
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 26
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims abstract description 21
- 238000006243 chemical reaction Methods 0.000 claims abstract description 19
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 239000013078 crystal Substances 0.000 claims abstract description 14
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 12
- ZOUYJERDNYMHCS-UHFFFAOYSA-N benzoyl chloride;dihydrochloride Chemical compound Cl.Cl.ClC(=O)C1=CC=CC=C1 ZOUYJERDNYMHCS-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000011114 ammonium hydroxide Nutrition 0.000 claims abstract description 9
- 239000012074 organic phase Substances 0.000 claims abstract description 8
- 150000002191 fatty alcohols Chemical class 0.000 claims abstract description 6
- 239000012535 impurity Substances 0.000 claims abstract description 6
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000002253 acid Substances 0.000 claims abstract description 3
- 239000011230 binding agent Substances 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- ABOLPUDOABZSNW-UHFFFAOYSA-N N1CCNCC1.CC1=C(C=C(C(=O)O)C=C1)C(=O)O Chemical compound N1CCNCC1.CC1=C(C=C(C(=O)O)C=C1)C(=O)O ABOLPUDOABZSNW-UHFFFAOYSA-N 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000003810 ethyl acetate extraction Methods 0.000 claims description 8
- 239000008346 aqueous phase Substances 0.000 claims description 7
- 238000005191 phase separation Methods 0.000 claims description 7
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract 3
- 239000012071 phase Substances 0.000 abstract 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 abstract 1
- 239000012295 chemical reaction liquid Substances 0.000 abstract 1
- 229960000582 mepyramine Drugs 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 239000005457 ice water Substances 0.000 description 20
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 238000010792 warming Methods 0.000 description 10
- 238000011084 recovery Methods 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 238000013019 agitation Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000012065 filter cake Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000010606 normalization Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 238000000967 suction filtration Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229960003685 imatinib mesylate Drugs 0.000 description 1
- YLMAHDNUQAMNNX-UHFFFAOYSA-N imatinib methanesulfonate Chemical compound CS(O)(=O)=O.C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 YLMAHDNUQAMNNX-UHFFFAOYSA-N 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000008806 mesenchymal cell neoplasm Diseases 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Pyridine Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102740021A CN101899035B (zh) | 2010-09-03 | 2010-09-03 | 一种高纯度伊马替尼的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102740021A CN101899035B (zh) | 2010-09-03 | 2010-09-03 | 一种高纯度伊马替尼的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101899035A true CN101899035A (zh) | 2010-12-01 |
CN101899035B CN101899035B (zh) | 2012-09-05 |
Family
ID=43224996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102740021A Active CN101899035B (zh) | 2010-09-03 | 2010-09-03 | 一种高纯度伊马替尼的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101899035B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796079A (zh) * | 2011-05-27 | 2012-11-28 | 江苏豪森医药集团连云港宏创医药有限公司 | 一种甲磺酸氟马替尼的制备方法 |
CN103848813A (zh) * | 2012-12-04 | 2014-06-11 | 北大方正集团有限公司 | 伊马替尼的制备方法 |
CN103910711A (zh) * | 2014-03-24 | 2014-07-09 | 福建天泉药业股份有限公司 | 一种伊马替尼游离碱晶型及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060173182A1 (en) * | 2003-02-18 | 2006-08-03 | Cipla Limited | Process of preparing imatinib and imatinib prepared thereby |
WO2008051597A1 (en) * | 2006-10-26 | 2008-05-02 | Sicor Inc. | Process for the preparation of imatinib |
-
2010
- 2010-09-03 CN CN2010102740021A patent/CN101899035B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060173182A1 (en) * | 2003-02-18 | 2006-08-03 | Cipla Limited | Process of preparing imatinib and imatinib prepared thereby |
WO2008051597A1 (en) * | 2006-10-26 | 2008-05-02 | Sicor Inc. | Process for the preparation of imatinib |
Non-Patent Citations (1)
Title |
---|
《中国药学杂志》 20080229 李铭东 等 甲磺酸伊马替尼的合成 第228-229页 1-5 第43卷, 第3期 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796079A (zh) * | 2011-05-27 | 2012-11-28 | 江苏豪森医药集团连云港宏创医药有限公司 | 一种甲磺酸氟马替尼的制备方法 |
CN102796079B (zh) * | 2011-05-27 | 2016-06-29 | 江苏豪森药业集团有限公司 | 一种甲磺酸氟马替尼的制备方法 |
CN103848813A (zh) * | 2012-12-04 | 2014-06-11 | 北大方正集团有限公司 | 伊马替尼的制备方法 |
CN103848813B (zh) * | 2012-12-04 | 2016-08-03 | 北大方正集团有限公司 | 伊马替尼的制备方法 |
CN103910711A (zh) * | 2014-03-24 | 2014-07-09 | 福建天泉药业股份有限公司 | 一种伊马替尼游离碱晶型及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101899035B (zh) | 2012-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104945299B (zh) | 一种维格列汀的高效合成方法 | |
CN105622609B (zh) | 一种利格列汀的制备方法 | |
CN105085360A (zh) | 一种高纯度维格列汀的制备方法 | |
CN104402838B (zh) | 缬沙坦的精制方法 | |
CN101899035B (zh) | 一种高纯度伊马替尼的制备方法 | |
CN104803976A (zh) | 一种苯甲酸阿格列汀原料药的工业生产方法 | |
CN102796079A (zh) | 一种甲磺酸氟马替尼的制备方法 | |
CN103601777A (zh) | 一种卡培他滨的制备方法 | |
CN102731436A (zh) | 一种瑞格列奈的制备及精制方法 | |
CN103804267B (zh) | 一种维达列汀的合成工艺 | |
CN108558759A (zh) | 一锅法制备塞来昔布的方法 | |
CN103980249A (zh) | 一种苯甲酸阿格列汀的精制方法 | |
CN104151291A (zh) | 一种苯甲酸阿格列汀多晶型晶体的制备方法 | |
CN105085531B (zh) | 一种西格列汀杂质合成方法 | |
CN103910685A (zh) | 一种提纯周效磺胺的方法 | |
CN106631978B (zh) | 一种米格列奈中间体的合成工艺 | |
CN112574203A (zh) | 制备高纯度利格列汀的方法 | |
CN108409657B (zh) | 高纯高乌甲素及其制备方法 | |
CN105712890A (zh) | 一种维格列汀中间体3-氨基-1-金刚烷醇的纯化工艺 | |
CN105111113A (zh) | 一种生产格列本脲的精制方法 | |
CN104817482A (zh) | 2-取代吡咯烷类化合物、制备方法及其在制备维格列汀中的应用 | |
CN104693177A (zh) | 一种埃索美拉唑钠的精制方法 | |
CN113402402B (zh) | 低浓度废液回收反式-对氨基环己醇的方法 | |
CN104650048B (zh) | 一种奥美沙坦酯缩合物的纯化方法 | |
CN104086533A (zh) | 一种埃索美拉唑的精制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of high-purity imatinib Effective date of registration: 20140320 Granted publication date: 20120905 Pledgee: Bank of Tianjin, Limited by Share Ltd, Hongqiao branch Pledgor: Tianjin Weijie Technology Co., Ltd. Registration number: 2014990000178 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20141030 Granted publication date: 20120905 Pledgee: Bank of Tianjin, Limited by Share Ltd, Hongqiao branch Pledgor: Tianjin Weijie Technology Co., Ltd. Registration number: 2014990000178 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of high-purity imatinib Effective date of registration: 20141031 Granted publication date: 20120905 Pledgee: Bank of Tianjin, Limited by Share Ltd, Hongqiao branch Pledgor: Tianjin Weijie Technology Co., Ltd. Registration number: 2014990000913 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20151021 Granted publication date: 20120905 Pledgee: Bank of Tianjin, Limited by Share Ltd, Hongqiao branch Pledgor: Tianjin Weijie Technology Co., Ltd. Registration number: 2014990000913 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of high-purity imatinib Effective date of registration: 20151021 Granted publication date: 20120905 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Wei Jie Technology Co., Ltd.|Tianjin Wei Czech Pharmaceutical Co., Ltd. Registration number: 2015990000906 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20161017 Granted publication date: 20120905 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Wei Jie Technology Co., Ltd.|Tianjin Wei Czech Pharmaceutical Co., Ltd. Registration number: 2015990000906 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of high-purity imatinib Effective date of registration: 20161017 Granted publication date: 20120905 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Wei Jie Technology Co., Ltd.|Tianjin Wei Czech Pharmaceutical Co., Ltd. Registration number: 2016990000880 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20171018 Granted publication date: 20120905 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Weijie Technology Co., Ltd.|Tianjin Weijie Pharmaceutical Co., Ltd. Registration number: 2016990000880 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of high-purity imatinib Effective date of registration: 20171018 Granted publication date: 20120905 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Weijie Technology Co., Ltd.|Tianjin Weijie Pharmaceutical Co., Ltd. Registration number: 2017990000966 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20181018 Granted publication date: 20120905 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Weijie Technology Co., Ltd.|Tianjin Weijie Pharmaceutical Co., Ltd. Registration number: 2017990000966 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of high-purity imatinib Effective date of registration: 20181018 Granted publication date: 20120905 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Weijie Technology Co., Ltd.|Tianjin Weijie Pharmaceutical Co., Ltd. Registration number: 2018990000977 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PM01 | Change of the registration of the contract for pledge of patent right | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20210930 Registration number: 2018990000977 Pledgee after: Bank of Tianjin Co.,Ltd. second center sub branch Pledgee before: Bank of Tianjin Limited by Share Ltd. Tianma subbranch |